Canada Pension Plan Investment Board Hutchmed (China) LTD Transaction History

Canada Pension Plan Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.63 - $15.52 $76,539 - $137,646	-8,869 Reduced 8.4%	96,676 $857,000
Q2 2022 Aug 12, 2022	BUY	$8.59 - $20.77 $174,763 - $422,565	20,345 Added 23.88%	105,545 $1.33 Million
Q1 2022 May 13, 2022	SELL	$15.52 - $35.65 $202,070 - $464,163	-13,020 Reduced 13.26%	85,200 $1.61 Million
Q3 2020 Nov 12, 2020	SELL	$25.8 - $34.61 $482,460 - $647,207	-18,700 Reduced 15.99%	98,220 $3.17 Million
Q2 2020 Aug 14, 2020	BUY	$17.65 - $28.05 $1.38 Million - $2.19 Million	78,246 Added 202.32%	116,920 $3.23 Million
Q1 2020 May 13, 2020	SELL	$15.19 - $29.51 $422,433 - $820,673	-27,810 Reduced 41.83%	38,674 $690,000
Q4 2019 Feb 14, 2020	BUY	$17.17 - $25.95 $1.14 Million - $1.73 Million	66,484 New	66,484 $1.67 Million
Q3 2019 Nov 12, 2019	SELL	$17.84 - $22.69 $1.38 Million - $1.75 Million	-77,334 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$23.09 - $37.69 $1.79 Million - $2.91 Million	77,334 New	77,334 $1.79 Million

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.47B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.